HEPATIC SAFETY AND ANTIRETROVIRAL EFFECTIVENESS IN HIV-INFECTED PATIENTS RECEIVING NALTREXONE

被引:0
|
作者
Tetrault, Jeanette [1 ]
McGinnis, Kathleen [2 ]
Sullivan, Lynn [3 ]
Fiellin, David [1 ]
Justice, Amy [4 ]
机构
[1] Yale Univ, Sch Med, New Haven, CT USA
[2] VA Pittsburgh Healthcare Syst, Pittsburgh, PA USA
[3] Yale Sch Med, New Haven, CT USA
[4] Yale Univ, Sch Med, West Haven, CT 06516 USA
关键词
D O I
暂无
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
引用
收藏
页码:293 / 293
页数:1
相关论文
共 50 条
  • [31] RENAL FUNCTION RAPIDLY DECREASES IN HIV-INFECTED PATIENTS RECEIVING ANTIRETROVIRAL THERAPY
    Hara, Masaki
    Ando, Minoru
    Yanagisawa, Naoki
    Tsuchiya, Ken
    Nitta, Kosaku
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30
  • [32] The clinical characteristics and antiretroviral dosing patterns of HIV-infected patients receiving dialysis
    Szczech, LA
    Kalayjian, R
    Rodriguez, R
    Gupta, S
    Coladonato, J
    Winston, J
    KIDNEY INTERNATIONAL, 2003, 63 (06) : 2295 - 2301
  • [33] Retention in Care Among HIV-infected Patients Receiving or Not Receiving Antiretroviral Therapy in Eastern Africa
    Reidy, William
    Agarwal, Mansi
    Chege, Duncan
    Lamb, Matthew
    Hawken, Mark
    Mukui, Irene
    Abrams, Elaine
    Geng, Elvin
    CLINICAL INFECTIOUS DISEASES, 2016, 63 (03) : 426 - +
  • [34] Safety of raltegravir-based antiretroviral therapy in HIV-infected patients receiving multi-kinase inhibitors
    Loulergue, Pierre
    Merad, Mansouria
    Coriat, Romain
    Ducreux, Michel
    Planchard, David
    Boige, Valerie
    Le Cesne, Axel
    Gregory, Thomas M.
    Poinsignon, Vianney
    Paci, Angelo
    Mir, Olivier
    INVESTIGATIONAL NEW DRUGS, 2017, 35 (02) : 247 - 249
  • [35] Safety of raltegravir-based antiretroviral therapy in HIV-infected patients receiving multi-kinase inhibitors
    Pierre Loulergue
    Mansouria Merad
    Romain Coriat
    Michel Ducreux
    David Planchard
    Valérie Boige
    Axel Le Cesne
    Thomas M. Gregory
    Vianney Poinsignon
    Angelo Paci
    Olivier Mir
    Investigational New Drugs, 2017, 35 : 247 - 249
  • [36] CSF escape in an HIV-infected patient receiving antiretroviral therapy
    Martins, J.
    Salgado, P.
    Santos, E.
    Marta, M.
    Franca, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 511 - 511
  • [37] Mitochondrial dysfunction in HIV-infected children receiving or not antiretroviral therapy
    Moren, C.
    Garrabou, G.
    Noguera, A.
    Nicolas, M.
    Cardellach, F.
    Fortuny, C.
    Miro, O.
    ANTIVIRAL THERAPY, 2008, 13 (08) : A82 - A82
  • [38] CLINICALLY SIGNIFICANT DRUG INTERACTIONS AMONG HIV-INFECTED PATIENTS RECEIVING ANTIRETROVIRAL THERAPY
    So-Ngern, Apichot
    Montakantikul, Preecha
    Manosuthi, Weerawat
    SOUTHEAST ASIAN JOURNAL OF TROPICAL MEDICINE AND PUBLIC HEALTH, 2014, 45 (05) : 1023 - 1031
  • [39] Effect of tuberculosis on immune restoration among HIV-infected patients receiving antiretroviral therapy
    Ghebremichael, Musie
    Habtemicael, Semere
    JOURNAL OF APPLIED STATISTICS, 2018, 45 (13) : 2357 - 2364
  • [40] Assessment of side effects coping practices of HIV-infected patients receiving antiretroviral therapy
    Agu, Kenneth Anene
    Oparah, Azuka Cyriacus
    Ochei, Uche M.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 (12) : 1302 - 1310